Confronta i metodi

	Punteggio di Wells per la TVP	Punteggio di gravità della polmonite CURB-65	Punteggio qSOFA
Campo	Valutazione clinica	Valutazione clinica	Valutazione clinica
Famiglia	Process / pipeline	Process / pipeline	Process / pipeline
Anno di origine	1994	2003	2016
Ideatore	Philip S. Wells	W. Staniford Lim, et al.	Sepsis-3 Taskforce
Tipo	Venous thromboembolism risk stratification	Community-acquired pneumonia severity assessment	Rapid sepsis screening
Fonte seminale	Wells, P. S., Hirsh, J., Anderson, D. R., et al. (1994). A simple clinical model for the diagnosis of deep-vein thrombosis combined with impedance plethysmography. Archives of Internal Medicine, 154(13), 1541-1546.	Lim, W. S., van der Eerden, M. M., Laing, R., et al. (2003). Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax, 58(5), 377-382.	Singer, M., Deutschman, C. S., Seymour, C. W., et al. (2016). The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA, 315(8), 801-810.
Alias	Wells DVT Score, DVT Wells	CURB-65, Pneumonia severity	Quick SOFA, qSOFA
Correlati	3	3	3
Sintesi	The Wells score, developed by Wells et al. in 1994, is a clinical prediction rule that stratifies patients into low, intermediate, or high pretest probability of deep vein thrombosis (DVT). It combines seven clinical features to guide diagnostic testing decisions and reduce unnecessary imaging in suspected DVT patients.	CURB-65, derived and validated by Lim et al. in 2003, is a 5-point severity of illness score for community-acquired pneumonia (CAP). It assesses confusion, urea nitrogen, respiratory rate, blood pressure, and age ≥65 years to stratify mortality risk and guide admission and treatment decisions.	The Quick Sequential Organ Failure Assessment (qSOFA) score, introduced by the Sepsis-3 taskforce in 2016, is a rapid 3-variable bedside screening tool for identifying non-ICU patients at high risk of sepsis-related mortality. It uses altered mentation, systolic hypotension, and tachypnea to quickly stratify patients without requiring laboratory testing.